Skip to main content

Donald Williams

Equibles does not estimate personal net worth.

Get an email with a short summary when Palisade Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get PALI alerts

About Donald Williams

Donald Williams is recorded as Board Member at Palisade Bio, Inc. (PALI) since January 1, 2021. The newest filing on record that lists Donald Williams as Board Member at Palisade Bio, Inc. (PALI) is dated May 22, 2024. Akari Therapeutics Plc reported in an 8-K filed November 14, 2024 that Donald Williams resigned as directors, effective November 13, 2024. Palisade Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palisade Bio, Inc. includes J.D. Finley (CEO, CFO and Board Member), Dane R. Saglio (CFO), Matthew W. Kalnik, Ph.D. (COO) and 7 others.

“Wa'el Hashad and Donald Williams resigned as directors of Akari and any committees thereof.”
Akari Therapeutics Plc Form 8-K, filed November 14, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2021-01-01–present

Leadership on record at Palisade Bio, Inc.

Recent activity